Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:DHAI NASDAQ:GMVDF OTCMKTS:INLB OTCMKTS:SIGY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.03$0.01$0.00▼$8.99$63K-0.36375 shs21 shsGMVDFG Medical Innovations$0.00-50.0%$0.00$0.00▼$0.03$26K43.1420,138 shs11,515 shsINLBItem 9 Labs$0.00$0.00▼$0.10$70K0.3525 shsN/ASIGYSigyn Therapeutics$0.04-9.1%$0.04$0.01▼$5.00$110KN/A74,870 shs4,502 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US0.00%0.00%+200.00%+2,900.00%-99.32%GMVDFG Medical Innovations0.00%+1,700.00%+3,500.00%+3,500.00%+1,700.00%INLBItem 9 Labs0.00%0.00%0.00%0.00%0.00%SIGYSigyn Therapeutics0.00%0.00%+29.03%-94.13%-98.75%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.03$0.01$0.00▼$8.99$63K-0.36375 shs21 shsGMVDFG Medical Innovations$0.00-50.0%$0.00$0.00▼$0.03$26K43.1420,138 shs11,515 shsINLBItem 9 Labs$0.00$0.00▼$0.10$70K0.3525 shsN/ASIGYSigyn Therapeutics$0.04-9.1%$0.04$0.01▼$5.00$110KN/A74,870 shs4,502 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US0.00%0.00%+200.00%+2,900.00%-99.32%GMVDFG Medical Innovations0.00%+1,700.00%+3,500.00%+3,500.00%+1,700.00%INLBItem 9 Labs0.00%0.00%0.00%0.00%0.00%SIGYSigyn Therapeutics0.00%0.00%+29.03%-94.13%-98.75%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDHAIDIH Holding US 1.00SellN/AN/AGMVDFG Medical Innovations 0.00N/AN/AN/AINLBItem 9 Labs 0.00N/AN/AN/ASIGYSigyn Therapeutics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDHAIDIH Holding US$62.86M0.00N/AN/A($19.61) per share0.00GMVDFG Medical Innovations$4.42M0.01N/AN/AN/A∞INLBItem 9 LabsN/AN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/A($2.78) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDHAIDIH Holding US-$8.68M-$6.30N/AN/AN/AN/AN/AN/AN/AGMVDFG Medical Innovations-$24.63MN/AN/AN/AN/AN/AN/AN/AN/AINLBItem 9 LabsN/A-$0.20N/AN/AN/AN/AN/AN/AN/ASIGYSigyn Therapeutics-$3.34M-$4.19N/AN/AN/AN/AN/A-3,743.20%5/19/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDHAIDIH Holding USN/AN/AN/AN/AN/AGMVDFG Medical InnovationsN/AN/AN/AN/AN/AINLBItem 9 LabsN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDHAIDIH Holding USN/AN/AN/AGMVDFG Medical InnovationsN/AN/AN/AINLBItem 9 LabsN/AN/AN/ASIGYSigyn TherapeuticsN/A0.020.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDHAIDIH Holding US27.76%GMVDFG Medical Innovations5.96%INLBItem 9 LabsN/ASIGYSigyn Therapeutics10.01%Insider OwnershipCompanyInsider OwnershipDHAIDIH Holding US27.00%GMVDFG Medical Innovations37.10%INLBItem 9 Labs19.80%SIGYSigyn Therapeutics78.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDHAIDIH Holding USN/A2.09 million1.53 millionN/AGMVDFG Medical Innovations72259.92 million163.49 millionNot OptionableINLBItem 9 Labs100701.81 million562.85 millionNot OptionableSIGYSigyn Therapeutics52.54 million548,000Not OptionableDHAI, SIGY, INLB, and GMVDF HeadlinesRecent News About These CompaniesSigyn Therapeutics Launches Initiative to Evaluate Emerging Medical Technologies in Former NFL Players at Risk of CTEApril 2, 2026 | finance.yahoo.comSigyn Therapeutics Delays Annual SEC FilingMarch 31, 2026 | tipranks.comScientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis(TM) to Treat Neuroinflammatory DiseasesMarch 24, 2026 | finance.yahoo.comSigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale InitiativesMarch 13, 2026 | finance.yahoo.comSigyn Therapeutics Issues Shareholder Update Highlighting the Advancement of CardioDialysis(TM) and New Corporate InitiativesJanuary 15, 2026 | finance.yahoo.comThe Emergence of Blood Purification Devices to Treat Cardiovascular DiseaseJanuary 7, 2026 | theglobeandmail.comSigyn Therapeutics Reports Third Quarter Financial Results and Subsequent Introduction of CardioDialysis(TM)November 14, 2025 | finance.yahoo.comSigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)November 6, 2025 | finance.yahoo.comSigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIXOctober 21, 2025 | newsfilecorp.comNSigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIXOctober 17, 2025 | newsfilecorp.comNSigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18thSeptember 16, 2025 | financialpost.comFSigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18thSeptember 16, 2025 | globenewswire.comSigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory BoardSeptember 11, 2025 | finance.yahoo.comSigyn Therapeutics Announces Cardiovascular Disease StudySeptember 3, 2025 | finance.yahoo.comSigyn Therapeutics Secures Convertible Note AgreementAugust 15, 2025 | msn.comSigyn Therapeutics Delays 10-Q FilingAugust 15, 2025 | tipranks.comRETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.July 1, 2025 | accessnewswire.comAGoldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.July 1, 2025 | accessnewswire.comASigyn Therapeutics Delays Q1 2025 10-Q FilingMay 15, 2025 | tipranks.comSigyn Therapeutics Delays Yearly Report FilingMarch 31, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDHAI, SIGY, INLB, and GMVDF Company DescriptionsDIH Holding US OTCMKTS:DHAI$0.03 0.00 (0.00%) As of 05/8/2026DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.G Medical Innovations NASDAQ:GMVDF$0.0001 0.00 (-50.00%) As of 05/8/2026 12:58 PM EasternG Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.Item 9 Labs OTCMKTS:INLBItem 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.Sigyn Therapeutics OTCMKTS:SIGY$0.04 0.00 (-9.09%) As of 05/8/2026 12:17 PM EasternSigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/04 - 05/08 SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
